Target intelligence / Profile preview

Chalcone synthase (CHS)

Target
CHS
Molecular classification
Enzyme, Type III polyketide synthase
01

Overview

Chalcone synthase is an enzyme ubiquitous in higher plants and is the first committed step of the flavonoid biosynthetic pathway, catalyzing the conversion of 4-coumaroyl-CoA and three molecules of malonyl-CoA into naringenin chalcone, a key intermediate for the synthesis of many flavonoids and isoflavonoids[1][3][4][5]. CHS is classified as a type III polyketide synthase, operates as a homodimer, and is highly conserved across land plants[2][3][4]. Flavonoids produced via this pathway play key roles in pigmentation, protection against ultraviolet radiation, plant fertility, antifungal defense, and interactions with beneficial microbes[1][3]. CHS activity is tightly regulated by metabolic and transcriptional signals in plants[3]. It is widely studied for its role in plant biology, not as a pharmaceutical target, with notable scientific history including being the first gene in which RNA interference was described[3].

Other names
naringenin-chalcone synthase
02

Mechanism of action

Not applicable in human drug context; catalyzes the condensation of 4-coumaroyl-CoA and three malonyl-CoA into naringenin chalcone in plants

03

Biological functions

Flavonoid biosynthesisIsoflavonoid biosynthesisPlant pigmentationUV protection in plantsPlant fertilityPlant antifungal defenseSymbiotic interactions with nitrogen-fixing bacteria
04

Disease associations

Other (primarily plant stress responses including pathogen defense; not a direct human disease target)
05

Safety considerations

None (no notable safety or toxicity issues in therapeutic context; not a direct drug target in humans)
06

Interacting drugs

None (no known pharmaceutical drugs; activity is relevant in plant metabolism, not targeted by drugs in medicine)
07

Biomarkers

None (used as a molecular marker in plant biology, such as expression studies, but not in human clinical use)

Beyond the preview

Go deeper on Chalcone synthase (CHS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chalcone synthase (CHS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call